In-vitro culture method of allogenic hepatocytes and application of in-vitro culture method

By conducting hypoxic environment culture in UI-P or PY21 culture medium without animal source material, the problem of poor fault tolerance of in vitro culture medium of animal-derived hepatocytes is solved, the number of passages is extended, the number and quality of cells is improved, and the The demand for industrialized production avoids the risk of animal-derived viruses.

CN118995572APending Publication Date: 2024-11-22SHANGHAI CRYOWISE MEDICAL TECH CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411262244.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-10
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing in vitro culture media without animal origin are poor in fault tolerance and are susceptible to mechanical and chemical factors, resulting in slow cell growth and limited number of passages cannot meet the needs of industrial production.

Method used

Using UI-P or PY21 culture medium without animal source raw materials, and culture of hepatocytes in a hypoxic environment, mediating gene expression by regulating hypoxia-inducing factors, promoting cell proliferation and division, prolonging passages, and increasing cell number and quality.

Benefits of technology

It realizes efficient in vitro culture of hepatocytes based on animal-free materials, avoids the risk of animal-derived viruses, meets the needs of large-scale industrial production, increases the number of cell passages and harvests, and ensures the establishment of cell banking. Second demand.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005036060820000051
    Figure BDA0005036060820000051
  • Figure BDA0005036060820000061
    Figure BDA0005036060820000061
  • Figure BDA0005036060820000091
    Figure BDA0005036060820000091
Patent Text Reader

Abstract

The invention discloses an allogenic hepatocyte in-vitro culture method. The method comprises the following steps: S1, obtaining hepatocytes: inoculating allogenic hepatocytes into a culture dish containing a culture medium; s2, cell passage: observing the adherence and growth states of the recovered cells, and performing cell passage operation until the cells are not amplified any more when the cell confluence degree reaches 80% or above. On the basis of not adopting a culture medium made of an animal-derived material, a low-oxygen-content culture environment is adopted, so that the passage frequency of a limited cell line is prolonged, further division of cells is promoted, the number of hepatocytes is increased, and the requirement for establishing generations of a cell bank is met. The adopted culture method is high in specificity and stable in culture, uniform, three-dimensional and high-amplification-capacity cells can be obtained, the cells grow fast, and the number of harvested cells is large.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to an in vitro culture method of allogeneic hepatocytes and application thereof, and relates to A61K, and in particular to the field of medical preparations. Background Art

[0002] Stem cell-derived liver progenitor-like cells obtained based on small molecule reprogramming technology can be used to treat severe liver diseases. With the in-depth development of technology, the use of animal-derived materials is avoided as much as possible in the production process of immune cell therapy products. On the one hand, it can reduce the toxicity from animal-derived materials, and on the other hand, it can achieve large-scale industrial production. However, culture media without animal-derived components have poor fault tolerance and higher requirements for the specificity of the culture media. Culture media without animal-derived components are easily affected by mechanical and chemical factors, which is not conducive to cell proliferation and differentiation. Cells grow slowly and the number of passages of limited cell lines is also reduced. Therefore, it is very important to develop an in vitro culture method for hepatocytes that can be passaged multiple times and uses a culture medium of non-animal origin.

[0003] Invention patent WO2016197274A1 discloses a method for preparing hepatocyte-like cells and cholangiocyte-like cells using human minor salivary gland epithelial stem / progenitor cells. Epithelial stem / progenitor cells are isolated and cultured from human minor salivary gland tissue in vitro, and further cultured and expanded in epithelial cell culture medium. After that, hepatocyte-like cells and cholangiocyte-like cells are induced to differentiate through planar culture or three-dimensional culture system in a hepatogenic induction medium containing growth factors. This is the proliferation and differentiation of hepatocytes by stem cells. The source of stem cells is small and the cost is high. Invention patent HK1188253A1 discloses a liver organoid, its use and a culture method for obtaining them. In the presence of a culture medium, epithelial stem cells and / or separated tissue fragments containing the epithelial stem cells are cultured in contact with an extracellular matrix. However, animal or human cells need to be added to the culture medium, and industrial applications have the risk of carrying viruses derived from animals. Summary of the invention

[0004] In order to develop an in vitro culture method for hepatocytes that can be passaged multiple times and uses a culture medium derived from non-animal sources, the first aspect of the present invention provides an in vitro culture method for allogeneic hepatocytes, comprising the following steps:

[0005] S1 Obtaining hepatocytes: inoculating allogeneic hepatocytes into a culture dish containing culture medium;

[0006] S2 cell passaging: observe the adherent growth state of allogeneic hepatocytes, and perform cell passaging when the cell confluence reaches more than 80%.

[0007] As a preferred embodiment, the culture medium is UI-P culture medium or PY21 culture medium, and the culture medium is a culture medium free of animal-derived raw materials.

[0008] As a preferred embodiment, the inoculation density of allogeneic hepatocytes in step S1 is 0.8×10 4 -2.0×10 4 Pieces / cm 2 .

[0009] As a preferred embodiment, the allogeneic hepatocytes in step S1 are derived from frozen hepatocytes or freshly isolated primary hepatocytes.

[0010] As a preferred embodiment, the specific steps of reviving the frozen hepatocytes are as follows:

[0011] M1: Place the frozen hepatocytes in a 37°C water bath and gently shake for 2 minutes until there are no obvious ice crystals in the tube;

[0012] M2: Wipe the outer surface of the cryotube with alcohol, open the cryotube cover in the biosafety cabinet, gently blow the bottom of the tube 2-3 times with a pipette, transfer the cell suspension to a 15mL centrifuge tube containing 10mL UI-P medium, and rinse the cryotube with 1mL UI-P medium;

[0013] M3 centrifugation, 200g for 4-8min;

[0014] M4 discarded the supernatant, resuspended the cell pellet with 2 mL UI-P medium, took 20 μL of the cell suspension and added 20 μL of 0.2% trypan blue staining solution, took 20 μL of the mixed solution and put it into the cell counting plate, and counted it with Countstar counter;

[0015] M5 Take two 10 cm culture dishes and add 10 mL UI-P medium to each dish. Inoculate one dish per condition with a seeding density of 2.0 × 10 4 Pieces / cm 2 .

[0016] As a preferred embodiment, the specific method of the cell passage operation comprises the following steps:

[0017] H1 aspirates and discards the culture supernatant in the culture dish;

[0018] Add 5 mL of H2 buffer to rinse the bottom of the bottle, discard the washing solution, and repeat this operation;

[0019] H3 was added with 5 mL of digestion solution and digested in an incubator;

[0020] After H4 digestion, round, clear cells were obtained, which fell off the bottom of the culture dish;

[0021] H5 then added 5 mL of buffer to form a cell suspension, which was placed in a centrifuge tube;

[0022] H6 centrifugation, 200g for 4-8min;

[0023] H7: resuspend the lower layer cell pellet after centrifugation with culture medium, mix well, stain and count the cells;

[0024] H8 was inoculated into a culture dish containing 10 mL of culture medium at a density of 2.0 × 10 4 Pieces / cm 2 , cross mixing;

[0025] H9 cells were transferred to an incubator for culture and subcultured when the cell confluence reached more than 80%.

[0026] As a preferred embodiment, when the P0 allogeneic hepatocytes in step S1 are derived from freshly isolated primary hepatocytes, PY21 culture medium is used at (0.8-1.2)×10 4 Pieces / cm 2 Density inoculation.

[0027] As a preferred embodiment, the culture conditions of the incubator in step H9 are 37° C., 1-10 vol% CO2, 1-10 vol% O2.

[0028] As a preferred embodiment, the culture conditions of the incubator in step H9 are 37° C., 2-8 vol% CO2, and 2-8 vol% O2.

[0029] As a preferred embodiment, the culture conditions of the incubator in step H9 are 37° C., 5 vol% CO 2 , and 4-6 vol% O 2 .

[0030] As a preferred embodiment, the culture conditions of the incubator in step H9 are 37° C., 5 vol% CO 2 , and 5 vol% O 2 .

[0031] As a preferred embodiment, the method for counting cells in step H7 is: taking the cell suspension and adding it into 0.2% trypan blue staining solution, mixing it and then putting the mixed solution into a cell counting plate, and counting it with a Countstar counter.

[0032] As a preferred embodiment, the buffer is PBS phosphate buffer.

[0033] As a preferred embodiment, the digestion conditions in step H3 are 37° C., 2-8 vol% CO 2 incubator for 5-10 min.

[0034] As a preferred embodiment, the digestion condition in step H3 is 37° C., 5 vol% CO 2 incubator for 5 minutes.

[0035] As a preferred embodiment, in step H9, if there are slow-living cells, if the cell confluence does not reach 80% after 3 days of inoculation, the culture medium is replaced and recorded. If the cell confluence still does not reach 80% after 3 days of continuous culture, the culture is terminated.

[0036] During the in vitro culture of hepatocytes, the inventors found that if non-animal-derived culture fluid is used as the culture medium, the hepatocytes will grow slowly in the in vitro culture medium, and the number of passages of the limited cell line will be reduced, which cannot meet the generation requirements for establishing a cell bank. During the experiment, the inventors found that cell culture in a hypoxic environment can prolong the number of cell passages, obtain uniform, three-dimensional amplified cells, and harvest a large number of cells. The possible reason is speculated to be: Under hypoxic environmental conditions, the expression of different genes can be mediated by regulating hypoxia-inducible factors, thereby regulating cell proliferation. The division ability of hepatocytes is inferior to that of stem cells themselves. The HIF1α signaling pathway can slow down the aging of hepatocytes during in vitro culture, which is beneficial to maintaining the cell state and promoting proliferation. Hypoxic conditions can promote further cell division and increase the number of hepatocytes.

[0037] The second aspect of the present invention provides an application of an in vitro culture method for allogeneic hepatocytes, which is applied to obtaining hepatic progenitor-like cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 The cell morphology under the microscope after multiple generations of culture of Comparative Example 1 and Example 1 is from P1 to P6 generations from top to bottom. The left picture is Comparative Example 1, and the right picture is Example 1.

[0039] Figure 2 The cell morphology under the microscope after multiple generations of culture of Comparative Example 1 and Example 1 is from P7 to P13 from top to bottom. The left picture is Comparative Example 1 and the right picture is Example 1. The cells of Comparative Example 1 were expanded to P8 and no longer expanded, so the experiment was stopped.

[0040] Figure 3 The cell morphology under a microscope after multiple generations of culture in Example 1 is shown, from top to bottom, from P14 to P16. In Example 1, the cell confluence was less than 80% when expanded to P16, and the culture was stopped.

[0041] Figure 4 The cell morphology of the P0 culture of Examples 2, 3, and 4 magnified 4 times under a microscope, from left to right are Examples 2, 3, and 4.

[0042] Figure 5The cell morphology of the P0-P4 generations cultured in Examples 2, 3, and 4 under a microscope magnified 4 times or 10 times, from left to right are Examples 2, 3, and 4, and from top to bottom are P0 generation 10 times, P1 generation 4 times, P1 generation 10 times, P2 generation 4 times, P2 generation 10 times, P3 generation 4 times, P3 generation 10 times, P4 generation 4 times, and P4 generation 10 times.

[0043] Compared with the prior art, the present invention has the following beneficial effects:

[0044] (1) The in vitro culture method of allogeneic hepatocytes described in the present invention does not use culture medium made from animal-derived materials, thus avoiding the potential risk of introduction of animal-derived viruses.

[0045] (2) The in vitro culture method of allogeneic hepatocytes described in the present invention does not use a culture medium of animal-derived materials, and can be used for large-scale industrial production for the in vitro culture of allogeneic hepatocytes, providing a source of drugs for the treatment of severe liver diseases.

[0046] (3) The in vitro culture method of allogeneic hepatocytes described in the present invention, without using culture medium of animal origin materials, adopts a low oxygen culture environment, thereby extending the number of passages of limited cell lines, promoting further cell division, increasing the number of hepatocytes, and meeting the generation requirements for establishing a cell bank.

[0047] (4) The in vitro culture method of allogeneic hepatocytes described in the present invention has a high specificity and stable culture method, and can obtain uniform, three-dimensional cells with strong proliferation ability. The cells grow quickly and a large number of cells can be harvested.

[0048] (5) The in vitro culture method of allogeneic hepatocytes described in the present invention optimizes the culture medium components and culture system, provides a reference basis for the planar culture conditions and process parameters of allogeneic hepatocytes, and provides a basis for the subsequent establishment of a tertiary cell bank. DETAILED DESCRIPTION

[0049] Example 1

[0050] An in vitro culture method for allogeneic hepatocytes comprises the following steps:

[0051] S1 Obtaining hepatocytes: inoculating allogeneic hepatocytes into a culture dish containing culture medium;

[0052] S2 cell passaging: observe the adherent growth state of allogeneic hepatocytes, and perform cell passaging when the cell confluence reaches more than 80%.

[0053] The allogeneic hepatocytes in step S1 are derived from cryopreserved hepatocytes. The hepatocytes are primary liver cells isolated by Shanghai Huicun Medical Technology Co., Ltd., and the freezing medium for the cryopreserved hepatocytes is purchased from BioLife Solutions, product name: CryostorCS10 Freeze Media.

[0054] The specific steps of reviving the frozen hepatocytes are as follows:

[0055] M1: Place the frozen hepatocytes in a 37°C water bath and gently shake for 2 minutes until there are no obvious ice crystals in the tube;

[0056] M2: Wipe the outer surface of the cryotube with alcohol, open the cryotube cover in the biosafety cabinet, gently blow the bottom of the tube 2-3 times with a pipette, transfer the cell suspension to a 15mL centrifuge tube containing 10mL UI-P medium, and rinse the cryotube with 1mL UI-P medium;

[0057] M3 centrifugation, 200g for 4-8min;

[0058] M4 discarded the supernatant, resuspended the cell pellet with 2 mL UI-P medium, took 20 μL of the cell suspension and added 20 μL of 0.2% trypan blue staining solution, took 20 μL of the mixed solution and put it into the cell counting plate, and counted it with Countstar counter;

[0059] M5 Take two 10 cm culture dishes and add 10 mL UI-P medium to each dish. Inoculate one dish per condition with a seeding density of 2.0 × 10 4 Pieces / cm 2 .

[0060] The material information of the UI-P culture medium is shown in Table 1

[0061] Table 1

[0062]

[0063]

[0064] The preparation method of the UI-P medium is as follows:

[0065] Place the beaker in a biosafety cabinet, place the magnetic stirrer in the beaker, measure the reagents according to the solution ingredient list and put them in the beaker, then place it on a magnetic stirrer, adjust the speed to 300-500 rpm, stir and mix thoroughly for 1 hour, use a PES membrane disposable sterile bottle top filter, set the pressure of the aspirator to ≤0.05Mpa for filtration, and divide it into portions for use.

[0066] The specific method of the cell passage operation comprises the following steps:

[0067] H1 aspirates and discards the culture supernatant in the culture dish;

[0068] Add 5 mL of H2 buffer to rinse the bottom of the bottle, discard the washing solution, and repeat this operation;

[0069] H3 was added with 5 mL of digestion solution and digested in an incubator;

[0070] After H4 digestion, round, clear cells were obtained, which fell off the bottom of the culture dish;

[0071] H5 then added 5 mL of buffer to form a cell suspension, which was placed in a centrifuge tube;

[0072] H6 centrifugation, 200 g for 5 min;

[0073] H7: resuspend the lower layer cell pellet after centrifugation with culture medium, mix well, stain and count the cells;

[0074] H8 was inoculated into a culture dish containing 10 mL of culture medium at a density of 2.0 × 10 4 Pieces / cm 2 , cross mixing;

[0075] H9 cells were transferred to an incubator for culture and subcultured when the cell confluence reached more than 80%.

[0076] The culture conditions of the incubator in step H9 are 37° C., 5 vol% CO 2 , and 1 vol% O 2 .

[0077] The method for counting cells in step H7 is as follows: taking the cell suspension and adding it into 0.2% trypan blue staining solution, mixing it evenly, taking the mixed solution and putting it into a cell counting plate, and counting it with a Countstar counter.

[0078] The buffer is PBS phosphate buffer, purchased from Yuanpei, item number: B210KJ.

[0079] The digestion and enzymatic hydrolysis solution is TrypLETMExpress digestion and enzymatic hydrolysis solution, purchased from Thermo-Gibco, item number: 12604021.

[0080] The digestion condition in step H3 is 37° C., 5 vol% CO 2 incubator for 5 min.

[0081] In the step H9, if there are slow-living cells, if the cell confluence does not reach 80% after 3 days of inoculation, the culture medium is replaced and recorded. If the cell confluence still does not reach 80% after 3 days of continuous culture, the culture is terminated.

[0082] Comparative Example 1

[0083] An in vitro culture method for allogeneic hepatocytes, the specific steps are the same as those in Example 1, except that the culture conditions of the incubator in step H9 are 37° C., 5 vol% CO2, and 20 vol% O2.

[0084] Example 2

[0085] An in vitro culture method for allogeneic hepatocytes comprises the following steps:

[0086] S1 Obtaining hepatocytes: inoculating allogeneic hepatocytes into a culture dish containing culture medium;

[0087] S2 cell passaging: observe the adherent growth state of allogeneic hepatocytes, and perform cell passaging when the cell confluence reaches more than 80%.

[0088] The allogeneic hepatocytes in step S1 are derived from freshly isolated primary hepatocytes. The allogeneic hepatocytes are primary hepatocytes isolated by Shanghai Huicun Medical Technology Co., Ltd.

[0089] The specific operation of step S1 is as follows:

[0090] M1: Transfer freshly isolated primary hepatocytes into a 15 mL centrifuge tube containing 10 mL of PY21 medium;

[0091] M3 centrifugation, 200 g for 5 min;

[0092] M4 discarded the supernatant, resuspended the cell pellet with 2 mL PY21 medium, took 20 μL of the cell suspension and added 20 μL of 0.2% trypan blue staining solution, took 20 μL of the mixed solution and put it into the cell counting plate, and counted it with Countstar counter;

[0093] M5 Take two 10 cm culture dishes and add 10 mL of PY21 medium to each dish. Inoculate one dish per condition with a seeding density of 1.2 × 10 4 Pieces / cm 2 .

[0094] The material information of the PY21 culture medium is shown in Table 2

[0095] Table 2

[0096] Material Name Manufacturer / Agent Part Number Feeding amount DMEM / F12 medium Shanghai Yuanpei X412KJ 9250mL Stemulate. Platelet lysate Sexton PL-NH-500 750mL AU-01 Novoprotein CJ72 2mL AU-05 TargetMol T1725 0.5mL AU-06 TargetMol T2310 1mL AU-07 Bikang Biotechnology 606-91-1 3mL AU-08 TargetMol T3031 2mL

[0097] The preparation method of the PY21 medium is as follows:

[0098] (1) Install the magnetic stirring bag in the LePure stirring system, open the liquid inlet, and add the materials in sequence;

[0099] (2) After the feeding is completed, seal the liquid inlet, turn on the LePure stirring system, set the speed to 90 rpm, and stir for 50 minutes. Filter, divide and set aside.

[0100] The specific method of the cell passage operation comprises the following steps:

[0101] H1 aspirates and discards the culture supernatant in the culture dish;

[0102] Add 5 mL of H2 buffer to rinse the bottom of the bottle, discard the washing solution, and repeat this operation;

[0103] H3 was added with 5 mL of digestion solution and digested in an incubator;

[0104] After H4 digestion, round, clear cells were obtained, which fell off the bottom of the culture dish;

[0105] H5 then added 5 mL of buffer to form a cell suspension, which was placed in a centrifuge tube;

[0106] H6 centrifugation, 200 g for 5 min;

[0107] H7: resuspend the lower layer cell pellet after centrifugation with culture medium, mix well, stain and count the cells;

[0108] H8 was inoculated into a culture dish containing 25 mL of culture medium at a density of 1.2 × 10 4 Pieces / cm 2 , cross mixing;

[0109] H9 cells were transferred to the incubator for culture and culture. When the cell confluence reached more than 80%, they were subcultured and cryopreserved at P4 after 4 consecutive subcultures.

[0110] The culture conditions of the incubator in step H9 are 37° C., 5 vol% CO 2 , and 1 vol% O 2 .

[0111] The method for counting cells in step H7 is as follows: taking the cell suspension and adding it into 0.2% trypan blue staining solution, mixing it evenly, taking the mixed solution and putting it into a cell counting plate, and counting it with a Countstar counter.

[0112] The buffer is PBS phosphate buffer, purchased from Yuanpei, item number: B210KJ.

[0113] The digestion and enzymatic hydrolysis solution is TrypLETMExpress digestion and enzymatic hydrolysis solution, purchased from Thermo-Gibco, item number: 12604021.

[0114] The digestion condition in step H3 is 37° C., 5 vol% CO 2 incubator for 5 min.

[0115] Example 3

[0116] An in vitro culture method for allogeneic hepatocytes, the specific steps are the same as those in Example 2, except that the culture conditions of the incubator in step H9 are 37° C., 5 vol% CO2, and 5 vol% O2.

[0117] Example 4

[0118] An in vitro culture method for allogeneic hepatocytes, the specific steps are the same as those in Example 2, except that the culture conditions of the incubator in step H9 are 37° C., 5 vol% CO2, and 20 vol% O2.

[0119] Performance Testing

[0120] The test data of Example 1 is shown in Table 3, the test data of Comparative Example 1 is shown in Table 4; the test data of Examples 2-4 is shown in Table 5.

[0121] Comparative Example 1: The cell morphology under the microscope after multiple generations of culture in Example 1 is shown in Figure 1-3 , the left picture is comparative example 1, and the right picture is embodiment 1. Figure 1 From top to bottom are P1 to P6 generations, Figure 2 From top to bottom are P7 to P13 generations, Figure 3 From top to bottom are P14 to P16 generations.

[0122] Table 3

[0123]

[0124]

[0125] Table 4

[0126]

[0127] Table 5

[0128]

[0129]

[0130] The test results show that: Comparative Example 1 can be passaged to P6, P7 cells no longer proliferate, and the cell morphology is abnormal, Example 1 can be passaged to P16, P15 PDL (the number of doublings of the cell population from the beginning of culture to the present) is still 2.0, meeting the library construction generation requirements.

[0131] The cell morphology of the P0-P4 cultures of Example 2-4 under a microscope magnified 4 times or 10 times is shown in Figure 4-5 . Figure 4 The cell morphology of the P0 culture of Examples 2, 3, and 4 is magnified 4 times under a microscope. From left to right are Examples 2, 3, and 4. Figure 5The cell morphology of the P0-P4 generations cultured in Examples 2, 3, and 4 under a microscope magnified 4 times or 10 times, from left to right are Examples 2, 3, and 4, and from top to bottom are P0 generation 10 times, P1 generation 4 times, P1 generation 10 times, P2 generation 4 times, P2 generation 10 times, P3 generation 4 times, P3 generation 10 times, P4 generation 4 times, and P4 generation 10 times.

[0132] The cell morphology of Example 3 was relatively uniform and three-dimensional at P1, and the cell proliferation ability was the strongest. When cultured to P4, the cells grew fastest and the number of harvested cells was large. The culture conditions of 37°C, 5vol% O2, and 5.0vol% CO2 were most suitable for the in vitro culture of allogeneic hepatocytes and could meet the needs of in vitro culture of allogeneic hepatocytes.

Claims

1. A method for culturing allogeneic hepatocytes in vitro, characterized in that: The following steps are involved: S1 Obtaining hepatocytes: inoculating allogeneic hepatocytes into a culture dish containing culture medium; S2 cell passaging: observe the adherent growth state of allogeneic hepatocytes, and perform cell passaging when the cell confluence reaches more than 80%.

2. The method for culturing allogeneic hepatocytes in vitro according to claim 1, characterized in that: The culture medium is UI-P culture medium or PY21 culture medium, and the culture medium is an animal-derived material-free culture medium.

3. The in vitro culture method of allogeneic hepatocytes according to claim 1, characterized in that: The seeding density of allogeneic hepatocytes in step S1 is 0.8×10 4 -2.0×10 4 Pieces / cm 2 .

4. The in vitro culture method of allogeneic hepatocytes according to claim 1, characterized in that: The specific method of the cell passage operation comprises the following steps: H1 aspirates and discards the culture supernatant in the culture dish; H2 was added to the buffer for washing; H3 was added to the digestion solution and digested in the incubator; After H4 digestion, round, clear cells were obtained, which fell off the bottom of the culture dish; H5 then added buffer to form a cell suspension, which was placed in a centrifuge tube; H6 centrifugation; H7: resuspend the lower layer cell pellet after centrifugation with culture medium, mix well, stain and count the cells; H8 was inoculated into a culture dish containing culture medium and mixed crosswise; H9 cells were transferred to an incubator for culture and subcultured when the cell confluence reached more than 80%.

5. The in vitro culture method of allogeneic hepatocytes according to claim 4, characterized in that: The culture conditions of the incubator in step H9 are 37° C., 1-10 vol% CO2, and 1-10 vol% O2.

6. The in vitro culture method of allogeneic hepatocytes according to claim 4, characterized in that: The method for counting cells in step H7 is as follows: taking the cell suspension and adding it into 0.2% trypan blue staining solution, mixing it evenly, taking the mixed solution and putting it into a cell counting plate, and counting it with a Countstar counter.

7. The in vitro culture method of allogeneic hepatocytes according to claim 4, characterized in that: The buffer is PBS phosphate buffer.

8. The in vitro culture method of allogeneic hepatocytes according to claim 4, characterized in that: The digestion condition in step H3 is 37° C., 2-8 vol% CO 2 incubator for 5-10 min.

9. The in vitro culture method of allogeneic hepatocytes according to claim 4, characterized in that: In the step H9, if there are slow-living cells, if the cell confluence does not reach 80% after 3 days of inoculation, the culture medium is replaced and recorded. If the cell confluence still does not reach 80% after 3 days of continuous culture, the culture is terminated.

10. An application of the method for culturing allogeneic hepatocytes in vitro according to any one of claims 1 to 9, characterized in that: Applied to the acquisition of hepatic progenitor-like cells.

Citation Information

Patent Citations

  • Method of preparing hepatocyte-like cells and bile duct-like cells using human minor salivary gland epithelial stem / progenitor cells and use thereof

    WO2016197274A1